ClinicalTrials.govpublic full text
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
asthma, safety, steroid reduction, efficacy, sb-240563, eosinophils, quality of life, mepolizumab, severe refractory asthma, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 845148
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.